Coronado Biosciences Inc. (CNDO): Chairman and CEO Harlan F. Weisman Bought 20,000 Shares
Chairman and CEO of Coronado Biosciences Inc. (CNDO) Harlan F. Weisman bought 20,000 shares on 01/14/2013 at an average price of $6.52. Coronado Biosciences Inc. is a biopharmaceutical company, engaged in the development of novel immunotherapy agents for cancer and inflammatory diseases. Coronado Biosciences Inc. has a market cap of $159 million; its shares were traded at around $6.52.
Cornado Biosciences recently reported its third quarter 2012 financial results. Coronado reported net losses of $5.9 million and $18.9 million for the three and nine months ended Sept. 30, 2012, respectively, compared to net losses of $3.4 million and $29.6 million for the three and nine months ended Sept. 30, 2011, respectively.
Glenn L. Cooper M.D. bought 3,811 shares of CNDO stock on 11/30/2012 at the average price of $4.02. Glenn L. Cooper M.D. owns at least 43,811 shares after this. The price of the stock has increased by 62.19% since.
For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.